| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |